Skip to main content

Human VEGF Quantikine QuicKit ELISA

R&D Systems, part of Bio-Techne | Catalog # QK293

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
QK293

Control Products Available

Key Product Details

Assay Length

80 minutes

Sample Type & Volume Required Per Well

Cell Culture Supernates (50 µL), Serum (50 µL), EDTA Plasma (50 µL), Heparin Plasma (50 µL), Saliva (25 µL), Urine (13 µL), Human Milk (10 µL)

Sensitivity

3.19 pg/mL

Assay Range

28.1-1800 pg/mL (Cell Culture Supernates, Serum, EDTA Plasma, Heparin Plasma, Saliva, Urine, Human Milk)

Product Summary for Human VEGF Quantikine QuicKit ELISA

The Quantikine™ QuicKit™ Human VEGF Immunoassay is a one step, 80-minute solid phase ELISA designed to measure human VEGF levels in cell culture supernates, serum, plasma, saliva, urine, and human milk. It contains Sf 21-expressed recombinant human VEGF and antibodies raised against the recombinant protein. Results obtained using natural human VEGF showed linear curves that were parallel to the standard curves obtained using the QuicKit standards. These results indicate that this kit can be used to determine relative mass values for natural human VEGF.

Product Specifications

Measurement

Quantitative ELISA

Detection Method

Colorimetric - 450nm (TMB)

Conjugate

HRP

Reactivity

Human

Specificity

Natural and recombinant human VEGF.

Cross-reactivity

< 0.5% cross-reactivity observed with available related molecules. < 50% cross-species reactivity observed with species tested.

Interference

No significant interference observed with available related molecules.

Sample Values

Serum/Plasma/Saliva/Urine/Human Milk - Samples from apparently healthy volunteers were evaluated for the presence of human VEGF in this assay. No medical histories were available for the donors used in this study.

Sample TypeMean (pg/mL)Range (pg/mL)Standard Deviation (pg/mL)
Serum (n=10)519175-1093352
EDTA plasma (n=10)79.440.6-18343.1
Heparin plasma (n=10)69.838.9-10523.7
Saliva (n=4)35212055-48801374
Urine (n=4)566219-1184429
Human milk (n=4)27,53523,100-31,8884620

Cell Culture Supernates:
PBMCs were isolated from a single donor over a Ficoll-Paque PLUS density gradient. PBMCs were seeded at 1 x 106 /mL and cultured in RPMI 1640 supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin sulfate. The cells were stimulated with 10 μg/mL PHA for 5 days. Aliquots of the cell culture supernatants were removed, assayed for human VEGF, and measured 169 pg/mL. 

JEG-3 human epithelial choriocarcinoma cells were cultured in MEM Earle's Salts and supplemented with 10% FBS. Cells were stimulated with 100 ng/mL of LPS for 24 hours. An aliquot of the cell culture supernate was removed, assayed for human VEGF, and measured 11,100 pg/mL. 

THP-1 acute monocytic leukemia cells were cultured in RPMI and supplemented with 10% fetal bovine serum. Cells were stimulated with 1 μg/mL Retionic Acid and 100 ng/mL PMA for 4 days. An aliquot of the cell culture supernate was removed, assayed for human VEGF, and measured 1829 pg/mL. 

PC-3 human prostate cancer cells were cultured in RPMI and supplemented with 10% fetal bovine serum until confluent. An aliquot of the cell culture supernate was removed, assayed for human VEGF, and measured 2366 pg/mL.

Precision

Intra-Assay Precision (Precision within an assay) Two samples of known concentration were tested twenty times on one plate to assess intra-assay precision.

Inter-Assay Precision (Precision between assays) Two samples of known concentration were tested in ten separate assays to assess inter-assay precision. Assays were performed by at least three technicians.

Cell Culture Supernates, EDTA Plasma, Heparin Plasma, Human Milk, Saliva, Serum, Urine

Intra-Assay Precision Inter-Assay Precision
Sample 1 2 1 2
n 20 20 10 10
Mean (pg/mL) 209 1193 203 1216
Standard Deviation 7.45 35.1 18.3 56.5
CV% 3.6 2.9 9.0 4.6

Recovery for Human VEGF Quantikine QuicKit ELISA

The recovery of human VEGF spiked to three levels in samples throughout the range of the assay was evaluated.

Sample Type Average % Recovery Range %
Cell Culture Media (n=4) 99 94-104
EDTA Plasma (n=2) 83 79-88
Heparin Plasma (n=2) 77 70-81
Human Milk (n=2) 102 98-105
Saliva (n=2) 104 97-115
Serum (n=2) 79 74-84
Urine (n=2) 78 70-85

Linearity

To assess the linearity of the assay, samples containing and/or spiked with high concentrations of human VEGF were diluted with calibrator diluent to produce samples with values within the dynamic range of the assay.

Scientific Data Images for Human VEGF Quantikine QuicKit ELISA

Human VEGF Standard Curve

Human VEGF QuicKit ELISA Spiked Linearity Competitor Comparison

Samples containing VEGF were diluted with appropriate Calibrator Diluent to produce samples with values within the dynamic range of the assay. The linearity is between 99%-107% compared to 100%-145% for the top competitor.

Preparation and Storage

Shipping

The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store the unopened product at 2 - 8 °C. Do not use past expiration date.

Background: VEGF

Vascular endothelial growth factor (VEGF or VEGF-A), also known as vascular permeability factor (VPF), is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult (1-3). It is a member of the PDGF family that is characterized by the presence of eight conserved cysteine residues in a cystine knot structure and the formation of antiparallel disulfide-linked dimers (4). Humans express alternately spliced isoforms of 121, 145, 165, 183, 189, and 206 amino acids (aa) in length (4). VEGF165 appears to be the most abundant and potent isoform, followed by VEGF121 and VEGF189 (3, 4). Isoforms other than VEGF121 contain basic heparin-binding regions and are not freely diffusible (4). Human VEGF165 shares 88% aa sequence identity with corresponding regions of mouse and rat VEGF. VEGF is expressed in multiple cells and tissues including skeletal and cardiac muscle (5, 6), hepatocytes (7), osteoblasts (8), neutrophils (9), macrophages (10), keratinocytes (11), brown adipose tissue (12), CD34+ stem cells (13), endothelial cells (14), fibroblasts, and vascular smooth muscle cells (15). VEGF expression is induced by hypoxia and cytokines such as IL-1, IL-6, IL-8, oncostatin M, and TNF-alpha (3, 4, 9, 16). VEGF isoforms are differentially expressed during development and in the adult (3). 
VEGF dimers bind to two related receptor tyrosine kinases, VEGF R1 (also called Flt-1) and VEGF R2 (Flk-1/KDR), and induce their homodimerization and autophosphorylation (3, 4, 7, 17, 18). These receptors have seven extracellular immunoglobulin-like domains and an intracellular split tyrosine kinase domain. They are expressed on vascular endothelial cells and a range of non-endothelial cells. Although VEGF affinity is highest for binding to VEGF R1, VEGF R2 appears to be the primary mediator of VEGF angiogenic activity (3, 4). VEGF165 also binds the semaphorin receptor, neuropilin-1, which promotes complex formation with VEGF R2 (19). 
VEGF is best known for its role in vasculogenesis. During embryogenesis, VEGF regulates the proliferation, migration, and survival of endothelial cells (3, 4), thus regulating blood vessel density and size, but playing no role in determining vascular patterns. VEGF promotes bone formation through osteoblast and chondroblast recruitment and is also a monocyte chemoattractant (20-22). After birth, VEGF maintains endothelial cell integrity and is a potent mitogen for micro- and macro-vascular endothelial cells. In adults, VEGF functions mainly in wound healing and the female reproductive cycle (3). In diseased tissues, VEGF promotes vascular permeability. It is thus thought to contribute to tumor metastasis by promoting both extravasation and tumor angiogenesis (23, 24). Various strategies have been employed therapeutically to antagonize VEGF-mediated tumor angiogenesis (25). Circulating VEGF levels correlate with disease activity in autoimmune diseases such as rheumatoid arthritis, multiple sclerosis and systemic lupus erythematosus (26).

Long Name

Vascular Endothelial Growth Factor

Alternate Names

MVCD1, VAS, Vasculotropin, VEGF-A, VEGFA, VPF

Entrez Gene IDs

7422 (Human); 22339 (Mouse); 83785 (Rat); 281572 (Bovine); 403802 (Canine); 493845 (Feline); 30682 (Zebrafish)

Gene Symbol

VEGFA

Additional VEGF Products

Product Documents for Human VEGF Quantikine QuicKit ELISA

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Human VEGF Quantikine QuicKit ELISA

For research use only

Loading...
Loading...